Many hospitals have implemented policies to restrict or ban the use of devices made of natural rubber latex (NRL) in healthcare as precautionary measures against the perceived risk of NRL allergy. Changes in glove technology, progress in measuring the specific allergenic potential of gloves and a dramatic decrease in the prevalence of NRL allergies after interventions and education prompted us to revisit the basis for justifiable glove selection policies. The published Anglophone literature from 1990 to 2010 was reviewed for original articles and reviews dealing with the barrier and performance properties of NRL and synthetic gloves and the role of glove powder. The review shows that NRL medical gloves, when compared with synthetic gloves, tend to be stronger, more flexible and better accepted by clinicians. The introduction of powder-free gloves has been associated with reductions in protein content and associated allergies. Recently, new methods to quantify clinically relevant NRL allergens have enabled the identification of gloves with low allergenic potential. The use of low-protein, low-allergenic, powder-free gloves is associated with a significant decrease in the prevalence of type I allergic reactions to NRL among healthcare workers. Given the excellent barrier properties and operating characteristics, dramatically reduced incidences of allergic reactions, availability of specific tests for selection of low-allergen gloves, competitive costs and low environmental impact, the use of NRL gloves within the hospital environment warrants reappraisal.

1.
Charous BL, Tarlo SM, Charous MA, Kelly K: Natural rubber latex allergy in the occupational setting. Methods 2002;27:15–21.
2.
Bousquet J, Flahault A, Vandenplas O, Ameille J, Duron JJ, Pecquet C, Chevrie K, Annesi-Maesano I: Natural rubber latex allergy among health care workers: a systematic review of the evidence. J Allerg Clin Immunol 2006;118:447–454.
3.
NHS Plus, Royal College of Physicians, Faculty of Occupational Medicine: Latex allergy: occupational aspects of management. A National Guideline. Royal College of Physicians, 2008. www.rcplondon.ac.uk/pubs/contents/f0ba0178-f790-48e8-a764-b319357f974a.pdf (accessed March 3, 2010).
4.
Pratt RJ, Pellowe CM, Wilson JA, Loveday HP, Harper PJ, Jones SR, McDougall C, Wilcox MH: Epic2:National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 2007;65(suppl 1):S1–S64.
5.
Kelly KJ: Is converting to synthetic gloves necessary? OR Manager 2008;24:14–15.
6.
Turjanmaa K, Reunala T: Contact urticaria from rubber gloves. Dermatol Clin 1988;6:47–51.
7.
Levy DA, Charpin D, Pecquet C, Leynadier F, Vervloet D: Allergy to latex. Allergy 1992;47:579–587.
8.
Slater JE: Latex allergy. J Allergy Clin Immunol 1994;94:139–149.
9.
Hunt LW, Fransway AF, Reed CE, Miller LK, Jones RT, Swanson MC, Yunginger JW: An epidemic of occupational allergy to latex involving health care workers. J Occup Environ Med 1995;37:1204–1209.
10.
Sussman GL, Beezhold DH: Allergy to latex rubber. Ann Intern Med 1995;122:43–46.
11.
Medical Devices Agency (UK): Latex Sensitisation in the Health Care Setting, MDA Device Bulletin (DB) 9601. London, Medicines and Healthcare Products Regulatory Agency, 1996.
12.
White L: Allergy challenges latex markets. Eur Rubber J 1994;176:1–5.
13.
Yip E, Turjanmaa K, Ng KP, Mok L: Allergic responses and levels of extractable proteins in NR latex gloves and dry rubber products. J Nat Rub Res 1994;9:79–86.
14.
Cohen DE, Scheman A, Stewart L, Taylor J, Pratt M, Trotter K, Prawer S, Warshaw E, Rietschel R, Watsky K, Schwarzenberger K, Zug K, Shama S, Godwin L, Kosann MK, Wilson BA: American Academy of Dermatology’s position paper on latex allergy. J Am Acad Dermatol 1998;39:98–106.
15.
Gottrup F, Müller K, Bergmark S, Nørregaard S: Powder-free, non-sterile gloves assessed in a wound healing centre. Eur J Surg 2001;167:625–627.
16.
Marcer G, Filon FL, Nardella R, Coco G: Latex allergy. Preventive measures in health care workers: a comparison of Italian experiences. Med Lav 2008;99:131–135.
17.
Hunt LW, Kelkar P, Reed CE, Yunginger JW: Management of occupational allergy to natural rubber latex in a medical center: the importance of quantitative latex allergen measurement and objective follow-up. J Allergy Clin Immunol 2002;110(suppl 2):S96–S106.
18.
Turjanmaa K, Kanto M, Kautiainen H, Reunala T, Palosuo T: Long-term outcome of 160 adult patients with natural rubber latex allergy. J Allergy Clin Immunol 2002;110(suppl 2):S70–S74.
19.
Allmers H, Schmengler J, Skudlik C: Primary prevention of natural rubber latex allergy in the German health care system through education and intervention. J Allergy Clin Immunol 2002;110:318–323.
20.
Kurup VP, Alenius H, Kelly KJ, Castillo L, Fink JN: A two-dimensional electrophoretic analysis of latex peptides reacting with IgE and IgG antibodies from patients with latex allergy. Int Arch Allergy Immunol 1996;109:58–67.
21.
Posch A, Chen Z, Wheeler C, Dunn MJ, Raulf-Heimsoth M, Baur X: Characterization and identification of latex allergens by two-dimensional electrophoresis and protein microsequencing. J Allergy Clin Immunol 1997;99:385–395.
22.
Sussman GL, Beezhold DH, Liss G: Latex allergy: historical perspective. Methods 2002;27:3–9.
23.
Nettis E, Assennato G, Ferrannini A, Tursi A: Type I allergy to natural rubber latex and type IV allergy to rubber chemicals in health care workers with glove-related skin symptoms. Clin Exp Allergy 2002;32:441–447.
24.
Yip E, Cacioli P: The manufacture of gloves from natural rubber latex. J Allergy Clin Immunol 2002;110(suppl):S3–S14.
25.
Perella FW, Gaspari AA: Natural rubber latex protein reduction with an emphasis on enzyme treatment. Methods 2002;27:77–86.
26.
Levy DA, Moudiki P, Leynadier F: Deproteinised latex condoms are well tolerated by latex allergic patients. Sex Transm Infect 2001;77:202–203.
27.
Mooibroek H, Cornish K: Alternative sources of natural rubber. Appl Microbiol Biotechnol 2000;53:355–365.
28.
Klein RC, Party E, Gershey EL: Virus penetration of examination gloves. Biotechniques 1990;9:196–199.
29.
Rego A, Roley L: In-use barrier integrity of gloves: latex and nitrile superior to vinyl. Am J Infect Control 1999;27:405–410.
30.
Korniewicz DM, El-Masri M, Broyles JM, Martin CD, O’Connell KP: Performance of latex and nonlatex medical examination gloves during simulated use. Am J Infect Control 2002;30:133–138.
31.
Walsh DL, Schwerin MR, Kisielewski RW, Kotz RM, Chaput MP, Varney GW, To TM: Abrasion resistance of medical glove materials. J Biomed Mater Res B Appl Biomater 2004;68:81–87.
32.
Korniewicz DM, Garzon L, Seltzer J, Feinleib M: Failure rates in nonlatex surgical gloves. Am J Infect Control 2004;32:268–273.
33.
Newsom SW, Smith MO, Shaw P: A randomised trial of the durability of non-allergenic latex-free surgical gloves versus latex gloves. Ann R Coll Surg Engl 1998;80:288–292.
34.
Aldlyami E, Kulkarni A, Reed MR, Muller SD, Partington PF: Latex-Free Gloves Safer for Whom? J Arthroplasty 2010;25:27–30.
35.
Scientific Committee on Medicinal Products and Medical Devices: Opinion on Natural Rubber Latex Allergy. Adopted by The Scientific Committee on Medicinal Products and Medical Devices on 27 June 2000. European Commission, 2000. http://ec.europa.eu/health/ph_risk/committees/scmp/documents/out31_en.pdf (accessed March 3, 2010).
36.
Sawyer J, Bennett A: Comparing the level of dexterity offered by latex and nitrile SafeSkin gloves. Ann Occup Hyg 2006;50:289–296.
37.
Naver LP, Gottrup F: Incidence of glove perforations in gastrointestinal surgery and the protective effect of double gloves: a prospective, randomised controlled study. Eur J Surg 2000;166:293–295.
38.
Chan KY, Singh VA, Oun BH: The rate of glove perforations in orthopaedic procedures: single versus double gloving. A prospective study. Med J Malaysia 2006;61(suppl B):3–7.
39.
St Germaine RL, Hanson J, de Gara CJ: Double gloving and practice attitudes among surgeons. Am J Surg 2003;185:141–145.
40.
Lefebvre DR, Strande LF, Hewitt CW: An enzyme-mediated assay to quantify inoculation volume delivered by suture needlestick injury: two gloves are better than one. J Am Coll Surg 2008;206:113–122.
41.
Quebbeman EJ, Telford GL, Wadsworth K, Hubbard S, Goodman H, Gottlieb MS: Double gloving. Protecting surgeons from blood contamination in the operating room. Arch Surg 1992;127:213–216.
42.
Wilson SJ, Sellu D, Uy A, Jaffer MA: Subjective effects of double gloves on surgical performance. Ann R Coll Surg Engl 1996;78:20–22.
43.
Tanner J: Choosing the right surgical glove: an overview and update. Br J Nurs 2008;17:740–744.
44.
Weissman DN, Lewis DM: Allergic and latex specific sensitization: route, frequency, and amount of exposure that are required to initiate IgE production. J Allergy Clin Immunol 2002;110(suppl 2):S57–S63.
45.
Wagner S, Breiteneder H: Hevea brasiliensis latex allergens: current panel and clinical relevance. Int Arch Allergy Immunol 2005;136:90–97.
46.
Ownby DR, Tomlanovich M, Sammons N, McCullough J: Anaphylaxis associated with latex allergy during barium enema examinations. AJR Am J Roentgenol 1991;156:903–908.
47.
Marchand R, Theoret S, Dion D, Pellerin M: Clinical implementation of a scrubless chlohexidene/ethanol pre-operative surgical hand rub. Can Oper Room Nurs J 2008;26:21–22, 26, 29–31.
48.
Poley E Jr, Slater JE: Latex allergy. J Allergy Clin Immunol 2000;105:1054–1062.
49.
Charous BL, Blanco C, Tarlo S, Hamilton RG, Baur X, Beezhold D, Sussman G, Yunginger JW: Natural rubber latex allergy after 12 years: recommendations and perspectives. J Allergy Clin Immunol 2002;109:31–34.
50.
Turjanmaa K, Alenius H, Mäkinen-Kiljunen S, Reunala T, Palosuo T: Natural rubber latex allergy. Allergy 1996;51:593–602.
51.
Chaiear N, Sadhra S, Jones M, Cullinan P, Foulds IS, Burge PS: Sensitisation to natural rubber latex: an epidemiological study of workers exposed during tapping and glove manufacture in Thailand. Occup Environ Med 2001;58:386–391.
52.
Cullinan P, Brown R, Field A, Hourihane J, Jones M, Kekwick R, Rycroft R, Stenz R, Williams S, Woodhouse C: British Society of Allergy and Clinical Immunology: Latex allergy. A position paper of the British Society of Allergy and Clinical Immunology. Clin Exp Allergy 2003;33:1484–1499.
53.
Allmers H, Schmengler J, John SM: Decreasing incidence of occupational contact urticaria caused by natural rubber latex allergy in German health care workers. J Allergy Clin Immunol 2004;114:347–351.
54.
Filon FL, Radman G: Latex allergy: a follow up study of 1,040 healthcare workers. Occup Environ Med 2006;63:121–125.
55.
Ranta PM, Ownby DR: A review of natural rubber latex allergy in health care workers. Clin Infect Dis 2004;38:252–256.
56.
LaMontagne AD, Radi S, Elder DS, Abramson MJ, Sim M: Primary prevention of latex related sensitisation and occupational asthma: a systematic review. Occup Environ Med 2006;63:359–364.
57.
Vandenplas O, Larbanois A, Vanassche F François S, Jamart J, Vandeweerdt M, Thimpont J: Latex-induced occupational asthma: time trend in incidence and relationship with hospital glove policies. Allergy 2009;64:415–420.
58.
Poole CJ, Nagendran V: Low prevalence of clinical latex allergy in UK health care workers: a cross-sectional study. Occup Med (Lond) 2001;51:510–512.
59.
Chowdhury MM, Statham BN: Natural rubber latex allergy in a health-care population in Wales. Br J Dermatol 2003;148:737–740.
60.
Mahler V, Fischer S, Fuchs T, Ghannadan M, Valent P, Fartasch M, Kraft D, Schuler G, Valenta R: Prevention of latex allergy by selection of low-allergen gloves. Clin Exp Allergy 2000;30:509–520.
61.
Liss GM, Tarlo SM: Natural rubber latex-related occupational asthma: association with interventions and glove changes over time. Am J Ind Med 2001;40:347–353.
62.
Saary MJ, Kanani A, Alghadeer H, Holness DL, Tarlo SM: Changes in rates of natural rubber latex sensitivity among dental school students and staff members after changes in latex gloves. J Allergy Clin Immunol 2002;109:131–135.
63.
Jones KP, Rolf S, Stingl C, Edmunds D, Davies BH: Longitudinal study of sensitization to natural rubber latex among dental school students using powder-free gloves. Ann Occup Hyg 2004;48:455–457.
64.
Turjanmaa K, Mäkinen-Kiljunen S: Latex allergy: prevalence, risk factors, and cross-reactivity. Methods 2002;27:10–14.
65.
Nettis E, Micale G, Fanelli M, Serio G, Colanardi MC, Ferrannini A, Tursi A: Atopy and risk factors for latex sensitization in a selected population. Allergy Asthma Proc 2003;24:185–191.
66.
Rodriguez M, Vega F, Garcia MT, Panizo C, Laffond E, Montalvo A, Cuevas M: Hypersensitivity to latex, chestnut, and banana. Ann Allergy 1993;70:31–34.
67.
Blanco C, Carrillo T, Castillo R, Quiralte J, Cuevas M: Latex allergy: clinical features and cross-reactivity with fruits. Ann Allergy 1994;73:309–314.
68.
Mäkinen-Kiljunen S: Banana allergy in patients with immediate-type hypersensitivity to natural rubber latex: characterization of cross-reacting antibodies and allergens. J Allergy Clin Immunol 1994;93:990–996.
69.
Ahlroth M, Alenius H, Turjanmaa K, Mäkinen-Kiljunen S, Reunala T, Palosuo T: Cross-reacting allergens in natural rubber latex and avocado. J Allergy Clin Immunol 1995;96:167–173.
70.
Ausili E, Tabacco F, Focarelli B, Nucera E, Patriarca G, Rendeli C: Prevalence of latex allergy in spina bifida: genetic and environmental risk factors. Eur Rev Med Pharmacol Sci 2007;11:149–153.
71.
Mazon A, Solera E, Alentado N, Oliver F, Pamies R, Caballero L, Nieto A, Dalmau J: Frequent IgE sensitization to latex, cow’s milk, and egg in children with short bowel syndrome. Pediatr Allergy Immunol 2008;19:180–183.
72.
Cremer R, Kleine-Diepenbruck U, Hering F, Holschneider AM: Reduction of latex sensitisation in spina bifida patients by a primary prophylaxis programme (five years experience). Eur J Pediatr Surg 2002;12(suppl 1):S19–S21.
73.
Buss ZS, Kupek E, Frode TS: Screening for latex sensitization by questionnaire: diagnostic performance in health care workers. J Invest Allergol Clin Immunol 2008;18:12–16.
74.
Ellis H: Pathological changes produced by surgical dusting powders. Ann R Coll Surg Engl 1994;76:5–8.
75.
Truscott W: Glove powder reduction and alternative approaches. Methods 2002;27:69–76.
76.
Turjanmaa K, Reunala T, Alenius H, Brummer-Korvenkontio H, Palosuo T: Allergens in latex surgical gloves and glove powder (letter). Lancet 1990;336:1588.
77.
Tomazic VJ, Shampaine EL, Lamanna A, Withrow TJ, Adkinson NF Jr, Hamilton RG: Cornstarch powder on latex products is an allergen carrier. J Allergy Clin Immunol 1994;93:751–758.
78.
Mitakakis TZ, Tovey ER, Yates DH, Toelle BG, Johnson A, Sutherland MF, O’Hehir RE, Marks GB: Particulate masks and non-powdered gloves reduce latex allergen inhaled by healthcare workers. Clin Exp Allergy 2002;32:1166–1169.
79.
Brown RH, Taenkhum K, Buckley TJ, Hamilton RG: Different latex aeroallergen size distributions between powdered surgical and examination gloves: significance for environmental avoidance. J Allergy Clin Immunol 2004;114:358–363.
80.
European Committee for Standardisation: CEN/TC205/WG3:pr EN 455-3:2006 Medical gloves for single use. Part 3. Requirements and testing for biological evaluation (approved by CEN 13 October 2006). Brussels, European Committee for Standardisation, 2006.
81.
Dalrymple SJ, Audley G: Allergenic products in dipped products: factors influencing extractable protein levels. Rubber Dev 1992;45:51–60.
82.
Kekwick RG: The modification of polypeptides in Hevea brasiliensis latex resulting from storage and processing. Clin Rev Allergy 1993;11:339–353.
83.
Palosuo T, Mäkinen-Kiljunen S, Alenius H, Reunala T, Yip E, Turjanmaa K: Measurement of natural rubber latex allergen levels in medical gloves by allergen-specific IgE-ELISA inhibition, RAST inhibition, and skin prick test. Allergy 1998;53:59–67.
84.
Palosuo T, Reinikka-Railo H, Kautiainen H, Alenius H, Kalkkinen N, Kulomaa M, Reunala T, Turjanmaa K: Latex allergy: the sum quantity of four major allergens shows the allergenic potential of medical gloves. Allergy 2007;62:781–786.
85.
Clayton TH, Wilkinson SM: Contact dermatoses in healthcare workers: reduction in type I latex allergy in a UK centre. Clin Exp Dermatol 2005;30:221–225.
86.
Miri S, Pourpak Z, Zarinara A, Heidarzade M, Kazemnejad A, Kardar G, Firooz A, Moin A: Prevalence of type I allergy to natural rubber latex and type IV allergy to latex and rubber additives in operating room staff with glove-related symptoms. Allergy Asthma Proc 2007;28:557–563.
87.
Sommer S, Wilkinson SM, Beck MH, English JS, Gawkrodger DJ, Green C: Type IV hypersensitivity reactions to natural rubber latex: results of a multicentre study. Br J Dermatol 2002;146:114–117.
88.
Knudsen B, Lerbaek A, Johansen JD, Mmenne T: Reduction in the frequency of sensitization to thiurams. A result of legislation? Contact Dermatitis 2006;54:170–171.
89.
Aalto-Korte K, Ackermann L, Henriks-Eckerman ML, Välimaa J, Reinikka-Railo H, Leppänen E, Jolanki R: 1,2-benzisothiazolin-3-one in disposable polyvinyl chloride gloves for medical use. Contact Dermatitis 2007;57:365–370.
90.
Lauren Y, Cao BS, Taylor JS, Sood C, Murray D, Siegel PD: Allergic contact dermatitis to synthetic rubber gloves. Changing trends in patch test reaction to accelerators. Arch Dermatol 2010;146:1001–1007.
91.
Ylitalo L, Mäkinen-Kiljunen S, Turjanmaa K, Palosuo T, Reunala T: Cow’s milk casein, a hidden allergen in natural rubber latex gloves. J Allergy Clin Immunol 1999;104:177–180.
92.
Ishikawa T, Kohno M, Osuna H, Ikezawa Z: Father and child with milk allergy and positive reactions to latex gloves on prick and use testing. Contact Dermatitis 2002;47:110–112.
93.
Heese A, Lacher U, Koch HU, Kubosch J, Ghane Y, Peters KP: Update on the latex allergy topic. Hautarzt 1996;47:817–824.
94.
Beezhold DH, Kostyal DA, Tomazic-Jezic VJ: Measurement of latex proteins and assessment of latex protein exposure. Methods 2002;27:46–51.
95.
Audo C, Barbara J, Chabane H, Armange M, Leynadier F: The EN 455–3 modified Lowry assay does not yield a reliable estimate of the allergenicity level of latex gloves with low total protein content. Med Sci Monit 2004;10:PI81–PI86.
96.
Rolland JM, O’Hehir RE: Latex allergy: a model for therapy. Clin Exp Allergy 2008;38:898–912.
97.
Palosuo T, Alenius H, Turjanmaa K: Quantitation of late allergens. Methods 2002;27:52–58.
98.
Peixinho C, Tavares-Ratado P, Tomás MR, Taborda-Barata L, Tomaz CT: Latex allergy: new insights to explain different sensitization profiles in different risk groups. Br J Dermatol 2008;159:132–136.
99.
Marchetti-Deschmann M, Allmaier G: Allergenic compounds on the inner and outer surfaces of natural rubber latex gloves: MALDI mass spectrometry and imaging proteinous allergens. J Mass Spectrom 2009;44:61–70.
100.
Palosuo T, Lehto M, Kotovuori A, Kalkkinen N, Blanco C, Poza P, Carrillo T, Hamilton RG, Alenius H, Reunala T, Turjanmaa K: Latex allergy: low prevalence of immunoglobulin E to highly purified proteins Hev b 2 and Hev b 13. Clin Exp Allergy 2007;37:1502–1511.
101.
Tomazic-Jezic VJ, Beezhold DH, Hashim H, Palosuo T, Raulf-Heimsoth M, Swanson M, Hamilton RG: Performance of methods for the measurement of natural rubber latex (NRL) proteins, antigens and allergens. J Allergy Clin Immunol 2004;113(suppl 1): S78.
102.
Yeang HY, Hamilton RG, Bernstein DI, Arif SA, Chow KS, Loke YH, Raulf-Heimsoth M, Wagner S, Breiteneder H, Biagini RE: Allergen concentrations in natural rubber latex. Clin Exp Allergy 2006;36:1078–1086.
103.
Biagini RE, Krieg EF, Pinkerton LE, Hamilton RG: Receiver operating characteristics analyses of Food and Drug Administration-cleared serological assays for natural rubber latex-specific immunoglobulin E antibody. Clin Diagn Lab Immunol 2001;8:1145–1149.
104.
Hamilton RG: Diagnosis of natural rubber latex allergy. Methods 2002;27:22–31.
105.
Biagini RE, MacKenzie BA, Sammons DL, Smith JP, Krieg EF, Robertson SA, Hamilton RG: Latex specific IgE: performance characteristics of the IMMULITE 2000 3gAllergy assay compared with skin testing. Ann Allergy Asthma Immunol 2006;97:196–202.
106.
Hamilton RG, Peterson EL, Ownby DR: Clinical and laboratory-based methods in the diagnosis of natural rubber latex allergy. J Allergy Clin Immunol 2002;110(suppl 2):S47–S56.
107.
Ebo DG, Hagendorens MM, De Knop KJ, Verweij MM, Bridts CH, De Clerck LS, Stewens WJ: Component-resolved diagnosis from latex allergy by microarray. Clin Exp Allergy 2010;40:348–358.
108.
Turjanmaa K, Palosuo T, Alenius H, Leynadier F, Autegarden JE, André C, Sicard H, Hrabina M, Tran TX: Latex allergy diagnosis: in vitro and in vivo standardization of a latex extract. Allergy 1997;52:41–50.
109.
Yip L, Hickey V, Wagner B, Liss G, Slater J, Breiteneder H, Sussman G, Beezhold D: Skin prick test reactivity to recombinant latex allergens. Int Arch Allergy Immunol 2000;121:292–299.
110.
Wagner S, Bublin M, Hafner C, Kopp T, Allwardt D, Seifert U, Arif SA, Scheiner O, Breiteneder H: Generation of allergen-enriched protein fractions of Hevea brasiliensis latex for in vitro and in vivo diagnosis. Int Arch Allergy Immunol 2007;143:246–254.
111.
Bernardini R, Pucci N, Azzari C, Novembre E, De Martino M, Milani M: Sensitivity and specificity of different skin prick tests with latex extracts in pediatric patients with suspected natural rubber latex allergy–a cohort study. Pediatr Allergy Immunol 2008;19:315–318.
112.
Turjanmaa K: Diagnosis of latex allergy. Allergy 2001;56:810–812.
113.
Berekaa MM, Linos A, Reichelt R, Keller U, Steinbüchel A: Effect of pretreatment of rubber material on its biodegradability by various rubber degrading bacteria. FEMS Microbiol Lett 2000;184:199–206.
114.
Yikmis M, Arenskotter M, Rose K, Lange N, Wernsmann H, Wiefel L, Steinbüchel A: Secretion and transcriptional regulation of the latex-clearing protein, lcp, by the rubber-degrading bacterium Streptomyces sp. Strain K30. App Environ Microbiol 2008;74:5373–5382.
115.
Morris M: Health considerations of synthetic alternatives to natural rubber latex. J Nat Rubber Res 1994;9:121–126.
116.
Rahaman WA: Natural rubber as a green commodity. Rubber Dev 1994;47:3–16.
117.
Korniewicz DM, Chookaew N, El-Masri M, Mudd K, Bollinger ME: Conversion to low-protein, powder-free surgical gloves: is it worth the cost? AAOHN J 2005;53:388–393.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.